IgG4-related disease: an update on pathophysiology and implications for clinical care
CA Perugino, JH Stone - Nature Reviews Rheumatology, 2020 - nature.com
Abstract IgG4-related disease (IgG4-RD) has only existed as a unique disease entity since
2003, yet remarkable progress has already been achieved in describing the essential …
2003, yet remarkable progress has already been achieved in describing the essential …
[HTML][HTML] ANCA-associated vasculitis: an update
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) represents a group
of small vessel vasculitides characterized by granulomatous and neutrophilic tissue …
of small vessel vasculitides characterized by granulomatous and neutrophilic tissue …
EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
In this article, the 2009 European League Against Rheumatism (EULAR) recommendations
for the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis …
for the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis …
[HTML][HTML] Efficacy of remission-induction regimens for ANCA-associated vasculitis
Background The 18-month efficacy of a single course of rituximab as compared with
conventional immunosuppression with cyclophosphamide followed by azathioprine in …
conventional immunosuppression with cyclophosphamide followed by azathioprine in …
[HTML][HTML] Rituximab versus cyclophosphamide for ANCA-associated vasculitis
JH Stone, PA Merkel, R Spiera, P Seo… - … England Journal of …, 2010 - Mass Medical Soc
Background Cyclophosphamide and glucocorticoids have been the cornerstone of
remission-induction therapy for severe antineutrophil cytoplasmic antibody (ANCA) …
remission-induction therapy for severe antineutrophil cytoplasmic antibody (ANCA) …
Long-term patient survival in ANCA-associated vasculitis
O Flossmann, A Berden, K de Groot, C Hagen… - Annals of the …, 2011 - ard.bmj.com
Background Wegener's granulomatosis and microscopic polyangiitis are antineutrophil
cytoplasm antibodies (ANCA)-associated vasculitides with significant morbidity and …
cytoplasm antibodies (ANCA)-associated vasculitides with significant morbidity and …
Granulomatosis with polyangiitis (Wegener): clinical aspects and treatment
C Comarmond, P Cacoub - Autoimmunity reviews, 2014 - Elsevier
Granulomatosis with polyangiitis (GPA) is a systemic necrotizing vasculitis, which affects
small-and medium-sized blood vessels and is often associated with cytoplasmic ANCA. GPA …
small-and medium-sized blood vessels and is often associated with cytoplasmic ANCA. GPA …
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
S Van Assen, N Agmon-Levin, O Elkayam… - Annals of the …, 2011 - ard.bmj.com
Objectives To develop evidence-based European League Against Rheumatism (EULAR)
recommendations for vaccination in patients with autoimmune inflammatory rheumatic …
recommendations for vaccination in patients with autoimmune inflammatory rheumatic …
Takayasu arteritis
GS Kerr, CW Hallahan, J Giordano… - Annals of internal …, 1994 - acpjournals.org
Objective: To evaluate prospectively the clinical features, angiographic findings, and
response to treatment of patients with Takayasu arteritis. Design: 60 patients with Takayasu …
response to treatment of patients with Takayasu arteritis. Design: 60 patients with Takayasu …
Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody—associated vasculitis: a randomized trial
K De Groot, L Harper, DRW Jayne… - Annals of internal …, 2009 - acpjournals.org
Background: Current therapies for antineutrophil cytoplasmic antibody (ANCA)–associated
vasculitis are limited by toxicity. Objective: To compare pulse cyclophosphamide with daily …
vasculitis are limited by toxicity. Objective: To compare pulse cyclophosphamide with daily …